{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:12:41Z","timestamp":1773299561707,"version":"3.50.1"},"reference-count":51,"publisher":"Portland Press Ltd.","issue":"9","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:p>Iron overload (IO) has been associated with glucose metabolism alterations and increased risk of cardiovascular disease (CVD). Primary IO is associated with mutations in the HFE gene. To which extent HFE gene mutations and metabolic alterations contribute to the presence of atherogenic lipoprotein modifications in primary IO remains undetermined. The present study aimed to assess small, dense low-density lipoprotein (LDL) levels, chemical composition of LDL and high-density lipoprotein (HDL) particles, and HDL functionality in IO patients. Eighteen male patients with primary IO and 16 sex- and age-matched controls were recruited. HFE mutations (C282Y, H63D and S65C), measures of insulin sensitivity and secretion (calculated from the oral glucose tolerance test), chemical composition and distribution profile of LDL and HDL subfractions (isolated by gradient density ultracentrifugation) and HDL functionality (as cholesterol efflux and antioxidative activity) were studied. IO patients compared with controls exhibited insulin resistance (HOMA-IR (homoeostasis model assessment-estimated insulin resistance): +93%, P&amp;lt; 0.001). Metabolic profiles differed across HFE genotypes. C282Y homozygotes (n=7) presented a reduced \u03b2-cell function and insulin secretion compared with non-C282Y patients (n=11) (\u221258% and \u221273%, respectively, P&amp;lt; 0.05). In addition, C282Y homozygotes featured a predominance of large, buoyant LDL particles (C282Y: 43\u00b15; non-C282Y: 25\u00b18; controls: 32\u00b17%; P&amp;lt; 0.001), whereas non-C282Y patients presented higher amounts of small, dense LDL (C282Y: 23\u00b15; non-C282Y: 39\u00b110; controls: 26\u00b14%; P&amp;lt; 0.01). HDL particles were altered in C282Y homozygotes. However, HDL functionality was conserved. In conclusion, metabolic alterations and HFE gene mutations are involved in the presence of atherogenic lipoprotein modifications in primary IO. To what extent such alterations could account for an increase in CVD risk remains to be determined.<\/jats:p>","DOI":"10.1042\/cs20140300","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T16:06:15Z","timestamp":1417622775000},"page":"609-618","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic alterations, HFE gene mutations and atherogenic lipoprotein modifications in patients with primary iron overload"],"prefix":"10.1042","volume":"128","author":[{"given":"Tom\u00e1s","family":"Mero\u00f1o","sequence":"first","affiliation":[{"name":"Laboratory of Lipids and Lipoproteins, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Jun\u00edn 956, 1113 Buenos Aires, Argentina"},{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Brites","sequence":"additional","affiliation":[{"name":"Laboratory of Lipids and Lipoproteins, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Jun\u00edn 956, 1113 Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolane","family":"Dauteuille","sequence":"additional","affiliation":[{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Lhomme","sequence":"additional","affiliation":[{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Menafra","sequence":"additional","affiliation":[{"name":"Laboratory of Lipids and Lipoproteins, School of Pharmacy and Biochemistry, INFIBIOC, University of Buenos Aires, CONICET, Jun\u00edn 956, 1113 Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Arteaga","sequence":"additional","affiliation":[{"name":"Hepatology Division, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Hemotherapy and Immunohematology, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda\u00a0Soledad","family":"Saez","sequence":"additional","affiliation":[{"name":"Central Laboratory, Italian Hospital of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban\u00a0Gonz\u00e1lez","family":"Ballerga","sequence":"additional","affiliation":[{"name":"Hepatology Division, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Sorroche","sequence":"additional","affiliation":[{"name":"Central Laboratory, Italian Hospital of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rey","sequence":"additional","affiliation":[{"name":"Department of Hemotherapy and Immunohematology, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lesnik","sequence":"additional","affiliation":[{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan\u00a0Andr\u00e9s","family":"Sord\u00e1","sequence":"additional","affiliation":[{"name":"Hepatology Division, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. John","family":"Chapman","sequence":"additional","affiliation":[{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[{"name":"National Institute for Health and Medical Research (INSERM), UMR ICAN 1166, University of Pierre et Marie Curie\u2013Paris 6, AP-HP, Groupe hospitalier Piti\u00e9-Salp\u00e9tri\u00e8re, ICAN, Paris F-75013, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Daruich","sequence":"additional","affiliation":[{"name":"Hepatology Division, Hospital \u201cJos\u00e9 de San Mart\u00edn\u201d, University of Buenos Aires, Buenos Aires, Argentina"},{"name":"Diagnostic and Therapeutical Gastroenterology (GEDYT), Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2015,2,11]]},"reference":[{"key":"2021113010380606500_B1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"2021113010380606500_B2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1517\/17530059.2013.763794","article-title":"Molecular diagnosis of hemochromatosis","volume":"7","author":"Piperno","year":"2013","journal-title":"Expert Opin. Med. Diagn."},{"key":"2021113010380606500_B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/aje\/154.3.193","article-title":"HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology","volume":"154","author":"Hanson","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"2021113010380606500_B4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1155\/2009\/839308","article-title":"Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study","volume":"23","author":"Adams","year":"2009","journal-title":"Can. J. Gastroenterol."},{"key":"2021113010380606500_B5","first-page":"31","article-title":"HFE gene mutations in patients with altered iron metabolism in Argentina","volume":"55","author":"Rossetti","year":"2009","journal-title":"Cell. Mol. Biol."},{"key":"2021113010380606500_B6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.23333","article-title":"Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors","volume":"51","author":"Fracanzani","year":"2010","journal-title":"Hepatology"},{"key":"2021113010380606500_B7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2006.11.014","article-title":"Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques","volume":"42","author":"Lapenna","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"2021113010380606500_B8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/01.ATV.0000124892.90999.cb","article-title":"Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper","volume":"24","author":"Stadler","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B9","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/S0735-1097(02)02611-6","article-title":"Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis","volume":"40","author":"Gaenzer","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010380606500_B10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCGENETICS.108.773176","article-title":"Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects","volume":"1","author":"van der","year":"2008","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2021113010380606500_B11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gene.2013.06.034","article-title":"Meta-analyses of HFE variants in coronary heart disease","volume":"527","author":"Lian","year":"2013","journal-title":"Gene"},{"key":"2021113010380606500_B12","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B13","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"key":"2021113010380606500_B14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-2362.2010.02429.x","article-title":"High risk of cardiovascular disease in iron overload patients","volume":"41","author":"Merono","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"2021113010380606500_B15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.metabol.2010.07.035","article-title":"Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis","volume":"60","author":"Casanova-Esteban","year":"2011","journal-title":"Metabolism"},{"key":"2021113010380606500_B16","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00125-006-0200-0","article-title":"High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis","volume":"49","author":"McClain","year":"2006","journal-title":"Diabetologia"},{"key":"2021113010380606500_B17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.metabol.2009.08.006","article-title":"Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis","volume":"59","author":"Hatunic","year":"2010","journal-title":"Metabolism"},{"key":"2021113010380606500_B18","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1210\/en.2004-0392","article-title":"Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis","volume":"145","author":"Cooksey","year":"2004","journal-title":"Endocrinology"},{"key":"2021113010380606500_B19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2007.08.009","article-title":"Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity","volume":"197","author":"de Souza","year":"2008","journal-title":"Atherosclerosis"},{"key":"2021113010380606500_B20","doi-asserted-by":"publisher","first-page":"e72763","DOI":"10.1371\/journal.pone.0072763","article-title":"Small, dense LDL particles predict changes in intima media thickness and insulin resistance in men with type\u00a02 diabetes and prediabetes\u2014a prospective cohort study","volume":"8","author":"Gerber","year":"2013","journal-title":"PLoS One"},{"key":"2021113010380606500_B21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2007.11.007","article-title":"Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome","volume":"199","author":"Gomez Rosso","year":"2008","journal-title":"Atherosclerosis"},{"key":"2021113010380606500_B22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00125-004-1655-5","article-title":"Defective antioxidative activity of small dense HDL3 particles in type\u00a02 diabetes: relationship to elevated oxidative stress and hyperglycaemia","volume":"48","author":"Nobecourt","year":"2005","journal-title":"Diabetologia"},{"key":"2021113010380606500_B23","first-page":"i\u2013xii","article-title":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ","volume":"894","author":"World Health Organization","year":"2000","journal-title":"Tech. Rep. Ser."},{"key":"2021113010380606500_B24","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"2021113010380606500_B25","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/dc14-S005","article-title":"Executive summary: standards of medical care in diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"2021113010380606500_B26","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1093\/nar\/18.19.5908","article-title":"Direct PCR from whole blood, without DNA extraction","volume":"18","author":"Mercier","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"2021113010380606500_B27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2021113010380606500_B28","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in\u00a0vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Muniyappa","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021113010380606500_B29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J. Lipid Res."},{"key":"2021113010380606500_B30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/01.ATV.16.6.763","article-title":"Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia","volume":"16","author":"Guerin","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B31","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010380606500_B32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/bbrc.1997.7872","article-title":"Human serum paraoxonase is inhibited in EDTA plasma","volume":"242","author":"Mackness","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113010380606500_B33","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/01.ATV.0000091338.93223.E8","article-title":"Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress","volume":"23","author":"Kontush","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B34","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/ATVBAHA.109.194548","article-title":"Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent","volume":"29","author":"Larrede","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.amjcard.2012.09.016","article-title":"Association of lipoprotein subfractions and coronary artery calcium in patient at intermediate cardiovascular risk","volume":"111","author":"Jug","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"2021113010380606500_B36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.atherosclerosis.2010.10.024","article-title":"Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort","volume":"214","author":"Williams","year":"2011","journal-title":"Atherosclerosis"},{"key":"2021113010380606500_B38","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.ajpath.2012.06.025","article-title":"Hepatic iron deposition does not predict extrahepatic iron loading in mouse models of hereditary hemochromatosis","volume":"181","author":"Subramaniam","year":"2012","journal-title":"Am. J. Pathol."},{"key":"2021113010380606500_B39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MCG.0b013e3181919a33","article-title":"Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes","volume":"43","author":"Cheng","year":"2009","journal-title":"J. Clin. Gastroenterol."},{"key":"2021113010380606500_B40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.trsl.2008.05.005","article-title":"HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) study","volume":"152","author":"Pankow","year":"2008","journal-title":"Transl. Res."},{"key":"2021113010380606500_B41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.104.496075","article-title":"Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case\u2013control study","volume":"112","author":"Ellervik","year":"2005","journal-title":"Circulation"},{"key":"2021113010380606500_B42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/01.wnl.0000257814.77115.d6","article-title":"Hereditary hemochromatosis genotypes and risk of ischemic stroke","volume":"68","author":"Ellervik","year":"2007","journal-title":"Neurology"},{"key":"2021113010380606500_B43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cca.2010.12.012","article-title":"Does non-alcoholic fatty liver impair alterations of plasma lipoproteins and associated factors in metabolic syndrome?","volume":"412","author":"Lucero","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"2021113010380606500_B44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/01.ATV.0000013284.47317.95","article-title":"Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women","volume":"22","author":"Carr","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0009-9120(96)00069-0","article-title":"Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease","volume":"29","author":"Schreier","year":"1996","journal-title":"Clin. Biochem."},{"key":"2021113010380606500_B46","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1161\/01.CIR.88.5.2180","article-title":"Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction","volume":"88","author":"Tornvall","year":"1993","journal-title":"Circulation"},{"key":"2021113010380606500_B47","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"2021113010380606500_B48","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","article-title":"Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities","volume":"27","author":"Kontush","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113010380606500_B49","doi-asserted-by":"publisher","first-page":"S202","DOI":"10.2337\/dc11-s221","article-title":"Type 2 diabetes can be prevented with early pharmacological intervention","volume":"34","author":"DeFronzo","year":"2011","journal-title":"Diabetes Care"},{"key":"2021113010380606500_B50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/dc07-0939","article-title":"Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations","volume":"31","author":"Equitani","year":"2008","journal-title":"Diabetes Care"},{"key":"2021113010380606500_B51","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.2105\/AJPH.2012.301163","article-title":"The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention","volume":"103","author":"Zacharski","year":"2013","journal-title":"Am. J. Public Health"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/128\/9\/609\/446912\/cs1280609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/128\/9\/609\/446912\/cs1280609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:29:02Z","timestamp":1638271742000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/128\/9\/609\/71262\/Metabolic-alterations-HFE-gene-mutations-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,11]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20140300","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,11]]}}}